[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Adoptive Cell Therapy Market Status, Trends and COVID-19 Impact Report 2022

October 2022 | 124 pages | ID: GF51E1FE61AFEN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Adoptive Cell Therapy market experienced a huge change under
the influence of COVID-19, the global market size of Adoptive Cell Therapy reached xx
million $ in 2021 from xx in 2016 with a CAGR of xx from 2016-2021 is. As of now, the
global COVID-19 Coronavirus Cases have exceeded 500 million, and the global epidemic has
been basically under control, therefore, the World Bank has estimated the global economic
growth in 2021 and 2022. The World Bank predicts that the global economic output is
expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research
on Adoptive Cell Therapy market and global economic environment, we forecast that the
global market size of Adoptive Cell Therapy will reach xx million $ in 2027 with a CAGR of
% from 2022-2027.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Adoptive Cell Therapy Market Status, Trends and
COVID-19 Impact Report 2022, which provides a comprehensive analysis of the global
Adoptive Cell Therapy market , This Report covers the manufacturer data, including: sales
volume, price, revenue, gross margin, business distribution etc., these data help the
consumer know about the competitors better. This report also covers all the regions and
countries of the world, which shows the regional development status, including market size,
volume and value, as well as price data. Besides, the report also covers segment data,
including: type wise, industry wise, channel wise etc. all the data period is from 2016-2021,
this report also provide forecast data from 2022-2027.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
CAR-T
TCR-T
NK
TIL

Application Segmentation
Lymphoma
Leukemia

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2022-2027)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source
SECTION 1 ADOPTIVE CELL THERAPY MARKET OVERVIEW

1.1 Adoptive Cell Therapy Market Scope
1.2 COVID-19 Impact on Adoptive Cell Therapy Market
1.3 Global Adoptive Cell Therapy Market Status and Forecast Overview
  1.3.1 Global Adoptive Cell Therapy Market Status 2016-2021
  1.3.2 Global Adoptive Cell Therapy Market Forecast 2022-2027

SECTION 2 GLOBAL ADOPTIVE CELL THERAPY MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Adoptive Cell Therapy Sales Volume
2.2 Global Manufacturer Adoptive Cell Therapy Business Revenue

SECTION 3 MANUFACTURER ADOPTIVE CELL THERAPY BUSINESS INTRODUCTION

3.1 Novartis Adoptive Cell Therapy Business Introduction
  3.1.1 Novartis Adoptive Cell Therapy Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.1.2 Novartis Adoptive Cell Therapy Business Distribution by Region
  3.1.3 Novartis Interview Record
  3.1.4 Novartis Adoptive Cell Therapy Business Profile
  3.1.5 Novartis Adoptive Cell Therapy Product Specification
3.2 Juno Adoptive Cell Therapy Business Introduction
  3.2.1 Juno Adoptive Cell Therapy Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.2.2 Juno Adoptive Cell Therapy Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 Juno Adoptive Cell Therapy Business Overview
  3.2.5 Juno Adoptive Cell Therapy Product Specification
3.3 Manufacturer three Adoptive Cell Therapy Business Introduction
  3.3.1 Manufacturer three Adoptive Cell Therapy Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.3.2 Manufacturer three Adoptive Cell Therapy Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Adoptive Cell Therapy Business Overview
  3.3.5 Manufacturer three Adoptive Cell Therapy Product Specification

SECTION 4 GLOBAL ADOPTIVE CELL THERAPY MARKET SEGMENTATION (BY REGION)

4.1 North America Country
  4.1.1 United States Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.1.2 Canada Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.1.3 Mexico Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
4.2 South America Country
  4.2.1 Brazil Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.2.2 Argentina Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
  4.3.1 China Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.3.2 Japan Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.3.3 India Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.3.4 Korea Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.3.5 Southeast Asia Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
4.4 Europe Country
  4.4.1 Germany Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.4.2 UK Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.4.3 France Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.4.4 Spain Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.4.5 Italy Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
  4.5.1 Africa Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
  4.5.2 Middle East Adoptive Cell Therapy Market Size and Price Analysis 2016-2021
4.6 Global Adoptive Cell Therapy Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Adoptive Cell Therapy Market Segmentation (By Region) Analysis

SECTION 5 GLOBAL ADOPTIVE CELL THERAPY MARKET SEGMENTATION (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 CAR-T Product Introduction
  5.1.2 TCR-T Product Introduction
  5.1.3 NK Product Introduction
  5.1.4 TIL Product Introduction
5.2 Global Adoptive Cell Therapy Sales Volume by TCR-T016-2021
5.3 Global Adoptive Cell Therapy Market Size by TCR-T016-2021
5.4 Different Adoptive Cell Therapy Product Type Price 2016-2021
5.5 Global Adoptive Cell Therapy Market Segmentation (By Type) Analysis

SECTION 6 GLOBAL ADOPTIVE CELL THERAPY MARKET SEGMENTATION (BY APPLICATION)

6.1 Global Adoptive Cell Therapy Sales Volume by Application 2016-2021
6.2 Global Adoptive Cell Therapy Market Size by Application 2016-2021
6.2 Adoptive Cell Therapy Price in Different Application Field 2016-2021
6.3 Global Adoptive Cell Therapy Market Segmentation (By Application) Analysis

SECTION 7 GLOBAL ADOPTIVE CELL THERAPY MARKET SEGMENTATION (BY CHANNEL)

7.1 Global Adoptive Cell Therapy Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Adoptive Cell Therapy Market Segmentation (By Channel) Analysis

SECTION 8 ADOPTIVE CELL THERAPY MARKET FORECAST 2022-2027

8.1 Adoptive Cell Therapy Segmentation Market Forecast 2022-2027 (By Region)
8.2 Adoptive Cell Therapy Segmentation Market Forecast 2022-2027 (By Type)
8.3 Adoptive Cell Therapy Segmentation Market Forecast 2022-2027 (By Application)
8.4 Adoptive Cell Therapy Segmentation Market Forecast 2022-2027 (By Channel)
8.5 Global Adoptive Cell Therapy Price Forecast

SECTION 9 ADOPTIVE CELL THERAPY APPLICATION AND CLIENT ANALYSIS

9.1 Lymphoma Customers
9.2 Leukemia Customers

SECTION 10 ADOPTIVE CELL THERAPY MANUFACTURING COST OF ANALYSIS

11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

SECTION 11 CONCLUSION

SECTION 12 METHODOLOGY AND DATA SOURCE

CHART AND FIGURE

Figure Adoptive Cell Therapy Product Picture
Chart Global Adoptive Cell Therapy Market Size (with or without the impact of COVID-19)
Chart Global Adoptive Cell Therapy Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Adoptive Cell Therapy Market Size (Million $) and Growth Rate 2016-2021
Chart Global Adoptive Cell Therapy Sales Volume (Units) and Growth Rate 2022-2027
Chart Global Adoptive Cell Therapy Market Size (Million $) and Growth Rate 2022-2027
Chart 2016-2021 Global Manufacturer Adoptive Cell Therapy Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Adoptive Cell Therapy Sales Volume Share
Chart 2016-2021 Global Manufacturer Adoptive Cell Therapy Business Revenue (Million
USD)
Chart 2016-2021 Global Manufacturer Adoptive Cell Therapy Business Revenue Share
Chart Novartis Adoptive Cell Therapy Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Novartis Adoptive Cell Therapy Business Distribution
Chart Novartis Interview Record (Partly)


More Publications